Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 148 | 124 | 0 | 0 | 0 |
| Operating Expenses | 61,603 | 32,610 | 34,513 | 32,601 | 25,089 |
| Operating Income | -61,455 | -32,486 | -34,513 | -32,601 | -25,089 |
| Interest Expense | N/A | 177 | 32 | 54 | 49 |
| Other Income | 2,211 | -8,931 | 3,357 | -3,197 | -1,210 |
| Pre-tax Income | -59,244 | -41,594 | -31,187 | -35,852 | -26,347 |
| Income Tax | 102 | 28 | 6 | 3 | -2,738 |
| Net Income Continuous | -59,346 | -41,622 | -31,193 | -35,855 | -23,609 |
| Net Income | $-59,346 | $-41,622 | $-31,193 | $-35,855 | $-23,609 |
| EPS Basic Total Ops | -0.70 | -1.65 | -2.25 | -3.67 | -3.02 |
| EPS Basic Continuous Ops | -0.70 | -1.65 | -2.25 | -3.67 | -3.02 |
| EPS Diluted Total Ops | -0.70 | -1.65 | -2.25 | -3.67 | -3.02 |
| EPS Diluted Continuous Ops | -0.70 | -1.65 | -2.25 | -3.67 | -3.02 |
| EBITDA(a) | $-60,864 | $-39,311 | $-28,846 | $-32,053 | $-23,109 |